84 related articles for article (PubMed ID: 2979057)
1. Immunotoxin preparation and testing in vitro.
Frankel AE; Welsh PC; Withers DI; Schlossman DM
Targeted Diagn Ther; 1988; 1():225-44. PubMed ID: 2979057
[No Abstract] [Full Text] [Related]
2. Enhancement of the cytotoxic effect of anti-carcinoembryonic antigen immunotoxins by adenovirus and carboxylic ionophores.
Griffin TW; Childs LR; FitzGerald DJ; Levin LV
J Natl Cancer Inst; 1987 Oct; 79(4):679-85. PubMed ID: 3498854
[TBL] [Abstract][Full Text] [Related]
3. [Preparation and study of cytotoxic properties of the immunotoxin anti-CD7/A-chain of ricin].
Tonevitskiĭ AG; Ershova GV; Agapov II; Toptygin AIu; Korotkova OV; Shereshkov SN; Kadagidze ZG; Baryshnikov AIu
Dokl Akad Nauk SSSR; 1991; 317(3):749-53. PubMed ID: 1720085
[No Abstract] [Full Text] [Related]
4. [Synthesis and properties of CD5-ricin immunotoxin].
Vikha GV; Uzhinova LD; Kashaeva AZh; Goshev VV; Krylov AV; Baryshnikov AIu; Vasilov RG
Biull Eksp Biol Med; 1995 Jan; 119(1):76-9. PubMed ID: 7536484
[No Abstract] [Full Text] [Related]
5. New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo.
Thorpe PE; Wallace PM; Knowles PP; Relf MG; Brown AN; Watson GJ; Knyba RE; Wawrzynczak EJ; Blakey DC
Cancer Res; 1987 Nov; 47(22):5924-31. PubMed ID: 3499221
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the cytotoxic activity of the immunotoxins with different internalization rate.
Tonevitsky AG; Agapov II; Mechetner EB; Ershova GV; Toptygin AYu ; Sarma T; Shamshiev AT; Pfueller U
Biochem Mol Biol Int; 1993 Dec; 31(6):1059-69. PubMed ID: 8193589
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells.
Blakey DC; Skilleter DN; Price RJ; Watson GJ; Hart LI; Newell DR; Thorpe PE
Cancer Res; 1988 Dec; 48(24 Pt 1):7072-8. PubMed ID: 3263899
[TBL] [Abstract][Full Text] [Related]
8. Specific killing of human T-leukemia cells by immunotoxins prepared with ricin A chain and monoclonal anti-human T-cell leukemia antibodies.
Seon BK
Cancer Res; 1984 Jan; 44(1):259-64. PubMed ID: 6606488
[TBL] [Abstract][Full Text] [Related]
9. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
Wiels J; Junqua S; Dujardin P; Le Pecq JB; Tursz T
Cancer Res; 1984 Jan; 44(1):129-33. PubMed ID: 6690030
[TBL] [Abstract][Full Text] [Related]
10. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.
Shah SA; Halloran PM; Ferris CA; Levine BA; Bourret LA; Goldmacher VS; Blättler WA
Cancer Res; 1993 Mar; 53(6):1360-7. PubMed ID: 7680284
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Jan; 44(1):201-8. PubMed ID: 6140077
[TBL] [Abstract][Full Text] [Related]
13. A humanized single-chain Fv fragment with high targeting potential against human malignant gliomas.
Ohtomo T; Kawata H; Sekimori Y; Shimizu K; Kishima H; Moriuchi S; Miyao Y; Akamatsu K; Tsuchiya M
Anticancer Res; 1998; 18(6A):4311-5. PubMed ID: 9891484
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F
Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879
[TBL] [Abstract][Full Text] [Related]
15. A carcinoembryonic antigen-directed immunotoxin built by linking a monoclonal antibody to a hemolytic toxin.
Avila AD; Mateo de Acosta C; Lage A
Int J Cancer; 1989 May; 43(5):926-9. PubMed ID: 2785509
[TBL] [Abstract][Full Text] [Related]
16. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.
Derocq JM; Casellas P; Laurent G; Ravel S; Vidal H; Jansen F
J Immunol; 1988 Oct; 141(8):2837-43. PubMed ID: 3262669
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic activities of conjugates of human transferrin and A subunits of plant toxins both in vitro and in vivo.
Tonevitsky AG; Demina IA; Agapov II; Fattakhova GV; Popova EN; Moysenovich MM; Komolov IS; Khalanskii AS; Kirpichnikov MP
Dokl Biochem; 2000; 374(1-6):210-3. PubMed ID: 11109967
[No Abstract] [Full Text] [Related]
19. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin.
Griffin TW; Pagnini PG; Houston LL
J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277
[TBL] [Abstract][Full Text] [Related]
20. Comparison of growth inhibition of a human ovarian adenocarcinoma cell line by free monoclonal antibodies and their corresponding antibody-recombinant ricin A chain immunotoxins.
Ettenson D; Sheldon K; Marks A; Houston LL; Baumal R
Anticancer Res; 1988; 8(4):833-8. PubMed ID: 3263079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
